€0.49
Your prediction
Financial data and news for Tempramed Technologies Ltd.
sharewise wants to provide you with the best news and tools for Tempramed Technologies Ltd., so we directly link to the best financial data sources.
Financials
News
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
Highlights
- Newly granted patent protects TempraMed’s VIVI Box™ proprietary, hassle-free thermal-insulation system and smart-monitoring architecture
- Expands the
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
A renowned expert in insulin pharmacology, diabetes technology, and temperature-sensitive medication stability joins TempraMed to strengthen scientific leadership.
Vancouver, BC – December
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
Vancouver, BC – December 8, 2025 – TempraMed Technologies Ltd. (“TempraMed” or the “Company”), a medical technology innovator transforming how temperature-sensitive medications are stored and
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
Vancouver, BC – December 5, 2025 – TempraMed Technologies Ltd. (“TempraMed” or the “Company”), a medical technology innovator transforming how temperature-sensitive medications are stored and
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
- Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
- Leading distributor of global companies including GSK/Haleon, Cargill, Reynolds, Paskesz
- Guri distributes reputable brands including Sensodyne, Aquafresh, Parodontax,